Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis.

Scioscia C, Scioscia M, Anelli MG, Praino E, Bettocchi S, Lapadula G.

Rheumatology Unit, Department of Internal Medicine and Public Health, University of Bari, Bari, Italy. ezio.scioscia@hotmail.com.

Abstract

OBJECTIVES: Rheumatoid arthritis is associated with an increased risk of adverse pregnancy outcomes. TNF inhibitors are effective in the treatment of signs and symptoms of the disease although their safety during pregnancy is debated.

METHODS: Two cases of women with rheumatoid arthritis in complete remission of the disease with etanercept who decided to continue the therapy throughout their pregnancy are presented. A longitudinal evaluation of the disease activity showed a satisfactory control and good pregnancy outcomes were obtained. A flare of the disease after delivery was not observed.

CONCLUSIONS: Etanercept seems to be safe during pregnancy and lactation. A good control of the activity of the disease was reported throughout the pregnancy and during puerperium, when a reactivation of rheumatoid arthritis is often observed.

RA患者妊娠期使用依那西普维持缓解

Scioscia C,et al.Clin Exp Rheumatol. 2011 Jan 19.

目的：RA与妊娠不良结局风险增高有关。TNF抑制剂能有效改善RA的体征和症状，但其妊娠期安全性有所争议。

方法：2例RA女性患者使用依那西普后达到完全缓解，她们决定在妊娠期继续治疗。纵向评估疾病活动度显示，病情得到有效控制，而且妊娠结局良好。分娩后疾病无复发。

结论：依那西普在妊娠期和哺乳期安全性好。妊娠期和产褥期疾病活动度控制良好，而这期间常可观察到RA复发。

转载于:https://www.cnblogs.com/T2T4RD/archive/2011/02/24/5464326.html

RA患者妊娠期使用依那西普维持缓解相关推荐

针对英夫利昔单抗或阿达木单抗的抗体存在与否决定转用依那西普的疗效
原文译文 Ann Rheum Dis 2011;70:284-288 doi:10.1136/ard.2010.135111 The presence or absence of antibodie ...
既往出现中性粒细胞减少的患者可以重新应用依那西普
原文译文 Clin Rheumatol. 2011 Aug 5. [Epub ahead of print] Re-challenge with Etanercept in patients wit ...
比较依那西普和柳氮磺胺吡碇治疗早期中轴脊柱关节炎1年后的停药缓解率和缓解时间－ESTHER试验的2年数据...
原文译文 Frequency and Duration of Drug-Free Remission After One Year of Treatment with Etanercept Vs. ...
比较依那西普单药与联合光疗治疗依那西普单药难治性银屑病
原文译文 J Dermatolog Treat. 2011 Aug 10. [Epub ahead of print] A randomized study comparing the combin ...
ACR2010_依那西普改善RA患者骨代谢
研究显示与对照组相比,RA患者血清CTX和硬骨素水平较低,这提示骨吸收速度较慢,以及骨生成较慢.依那西普治疗后,骨转换标记物升高,炎性指标下降.因此我们认为依那西普在抑制炎症的同时,能刺激RA患者降低 ...
依那西普治疗日本RA患者的安全性与疗效的上市后监察
原文译文 Mod Rheumatol. 2011 Jan 25. [Epub ahead of print] Postmarketing surveillance of safety and eff ...
【ACR2015】依那西普按需维持治疗策略有效抑制RA骨破坏进展
标签: 类风湿关节炎; 依那西普; 药物减停; 复发重治对RA疾病复发患者, 依那西普按需治疗与持续足剂量治疗是否存在疗效差异? Inui K, et al. ACR 2015. Presentat ...
常规诊疗条件下比较依那西普生物类似药(益赛普)与阿达木、英夫利西对RA的疗效[EULAR2015_SAT0360]...
常规诊疗条件下比较依那西普生物类似药(益赛普)与阿达木单抗.英夫利西单抗治疗RA的临床疗效 SAT0360 ETANAR - A ETANERCEPT BIOSIMILAR IS AS EFFEC ...
依那西普血清水平与强直性脊柱炎患者疗效无相关性
依那西普血清水平与强直性脊柱炎患者疗效无相关性 De Vries MK, Wolbink GJ, et al. EULAR 2007. Present ID: FRI0382. 背景:我们最近的一研究 ...

RA患者妊娠期使用依那西普维持缓解

Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis.

Abstract

RA患者妊娠期使用依那西普维持缓解相关推荐

最新文章

热门文章